SAG
GILD icon

SageView Advisory Group’s Gilead Sciences GILD Stock Holding History

SageView Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.76M Sell
22,481
-1,459
-6% -$177K 0.09% 125
2025
Q3 		$2.66M Buy
23,940
+14,715
+160% +$1.67M 0.09% 134
2025
Q2 		$1.04M Buy
9,225
+2,425
+36% +$258K 0.04% 234
2025
Q1 		$762K Sell
6,800
-377
-5% -$38.9K 0.03% 266
2024
Q4 		$663K Sell
7,177
-369
-5% -$33.2K 0.03% 293
2024
Q3 		$633K Sell
7,546
-1,071
-12% -$81.7K 0.03% 259
2024
Q2 		$591K Buy
+8,617
New +$575K 0.03% 307
2024
Q1 		– Sell
-20,719
Closed -$1.63M – 602
2023
Q4 		$1.63M Buy
20,719
+1,791
+9% +$139K 0.07% 178
2023
Q3 		$1.42M Sell
18,928
-74
-0.4% -$5.69K 0.08% 159
2023
Q2 		$1.46M Buy
19,002
+752
+4% +$60K 0.08% 165
2023
Q1 		$1.51M Buy
18,250
+13,632
+295% +$1.13M 0.1% 140
2022
Q4 		$396K Buy
+4,618
New +$366K 0.03% 276

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SageView Advisory Group's GILD Position: Q4 2025 in Review

SageView Advisory Group reduced its Gilead Sciences (GILD) stake by 6.1% in Q4 2025, selling an estimated $177K and leaving 22,481 shares worth $2.76M. The position accounts for 0.09% of the portfolio, ranked #125.

SageView Advisory Group first reported a position in GILD in Q4 2022 and has held it in 12 quarters since. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • SageView Advisory Group held 22,481 shares of Gilead Sciences worth $2.76M as of Q4 2025.
  • SageView Advisory Group sold 1,459 Gilead Sciences shares in Q4 2025, an estimated $177K.
  • Gilead Sciences made up 0.09% of SageView Advisory Group's portfolio in Q4 2025, its #125 holding.
  • SageView Advisory Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 12 quarters since.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.